全文获取类型
收费全文 | 155892篇 |
免费 | 10315篇 |
国内免费 | 776篇 |
专业分类
耳鼻咽喉 | 1443篇 |
儿科学 | 3979篇 |
妇产科学 | 2837篇 |
基础医学 | 20840篇 |
口腔科学 | 3490篇 |
临床医学 | 15066篇 |
内科学 | 33549篇 |
皮肤病学 | 2907篇 |
神经病学 | 15060篇 |
特种医学 | 6225篇 |
外国民族医学 | 6篇 |
外科学 | 23447篇 |
综合类 | 1949篇 |
现状与发展 | 2篇 |
一般理论 | 139篇 |
预防医学 | 11416篇 |
眼科学 | 3230篇 |
药学 | 10664篇 |
2篇 | |
中国医学 | 252篇 |
肿瘤学 | 10480篇 |
出版年
2023年 | 827篇 |
2022年 | 1260篇 |
2021年 | 2862篇 |
2020年 | 1976篇 |
2019年 | 2851篇 |
2018年 | 3475篇 |
2017年 | 2684篇 |
2016年 | 3080篇 |
2015年 | 3545篇 |
2014年 | 5086篇 |
2013年 | 6891篇 |
2012年 | 10658篇 |
2011年 | 11283篇 |
2010年 | 6412篇 |
2009年 | 6116篇 |
2008年 | 10323篇 |
2007年 | 10991篇 |
2006年 | 10461篇 |
2005年 | 10687篇 |
2004年 | 10112篇 |
2003年 | 9596篇 |
2002年 | 9039篇 |
2001年 | 1591篇 |
2000年 | 1200篇 |
1999年 | 1682篇 |
1998年 | 2149篇 |
1997年 | 1688篇 |
1996年 | 1443篇 |
1995年 | 1316篇 |
1994年 | 1175篇 |
1993年 | 1142篇 |
1992年 | 847篇 |
1991年 | 858篇 |
1990年 | 665篇 |
1989年 | 649篇 |
1988年 | 621篇 |
1987年 | 638篇 |
1986年 | 563篇 |
1985年 | 590篇 |
1984年 | 669篇 |
1983年 | 588篇 |
1982年 | 770篇 |
1981年 | 727篇 |
1980年 | 623篇 |
1979年 | 401篇 |
1978年 | 399篇 |
1977年 | 421篇 |
1976年 | 360篇 |
1975年 | 310篇 |
1974年 | 288篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
52.
53.
Tsuen‐Chiuan Tsai Peter H Harasym Sylvain Coderre Kevin McLaughlin Tyrone Donnon 《Medical education》2009,43(12):1188-1197
Context The assessment of ethical problem solving in medicine has been controversial and challenging. The purposes of this study were: (i) to create a new instrument to measure doctors’ decisions on and reasoning approach towards resolving ethical problems; (ii) to evaluate the scores generated by the new instrument for their reliability and validity, and (iii) to compare doctors’ ethical reasoning abilities between countries and among medical students, residents and experts. Methods This study used 15 clinical vignettes and the think‐aloud method to identify the processes and components involved in ethical problem solving. Subjects included volunteer ethics experts, postgraduate Year 2 residents and pre‐clerkship medical students. The interview data were coded using the instruments of the decision score and Ethical Reasoning Inventory (ERI). The ERI assessed the quality of ethical reasoning for a particular case (Part I) and for an individual globally across all the vignettes (Part II). Results There were 17 Canadian and 32 Taiwanese subjects. Based on the Canadian standard, the decision scores between Taiwanese and Canadian subjects differed significantly, but made no discrimination among the three levels of expertise. Scores on the ERI Parts I and II, which reflect doctors’ reasoning quality, differed between countries and among different levels of expertise in Taiwan, providing evidence of construct validity. In addition, experts had a greater organised knowledge structure and considered more relevant variables in the process of arriving at ethical decisions than did residents or students. The reliability of ERI scores was 0.70–0.99 on Part I and 0.75–0.80 on Part II. Conclusions Expertise in solving ethical problems could not be differentiated by the decisions made, but could be differentiated according to the reasoning used to make those decisions. The difference between Taiwanese and Canadian experts suggests that cultural considerations come into play in the decisions that are made in the course of providing humane care to patients. 相似文献
54.
OBJECTIVE: Based on recent safety and efficacy data, combined with the known pharmacokinetic parameters of aminoglycosides in the newborn, once-daily gentamicin should be preferable to the many other dosing regimens currently in use. Although there are growing data to support its use in term newborns, experience with preterm infants is more limited. In our Neonatal Intensive Care Unit, we experienced difficulties regarding complicated dosing regimens, actual dosing errors, and the tendency to check trough and peak levels around the third dose for infants receiving only a 48 hour course. Therefore, we conducted a quality improvement initiative in which we developed and tested a clinical practice guideline for the use of once-daily gentamicin for preterm and term infants that we hoped would yield trough and peak levels in our target range. METHODS: We combined a review of the published English language literature with pharmacokinetic analysis of our own data prior to initiation of this new regimen to design the following dosing regimen: <35 weeks gestation: 3 mg/kg q 24 hours, > or =35 weeks gestation: 4 mg/kg q 24 hours. Our goal serum levels were a trough < or =2 microg/ml and a peak between 6 and 12 microg/ml. We collected and analyzed trough and peak levels from all infants receiving this dosing regimen in the first week of life for at least 72 hours between 3/1/99 and 12/31/00. RESULTS: In total, 214 babies met our inclusion criteria, 75 of whom were <35 weeks gestation. 100% of babies of all gestational ages had a nontoxic trough level. For infants <35 weeks gestation, 79% had a therapeutic peak level, with a mean value of 6.8 microg/ml. For infants of at least 35 weeks gestation, 93% had a therapeutic peak level, with a mean value of 8.4 microg/ml. 92% of nontherapeutic peaks were too low. CONCLUSION: This study of once-daily gentamicin represents the largest sample size of pre-term infants published to date. The proposed regimen is simple and yields a high proportion of desirable levels. We recommend it for use in preterm and term newborns. 相似文献
55.
56.
Sumon Nandi Steven Maschke Peter J. Evans Jeffrey N. Lawton 《Hand (New York, N.Y.)》2009,4(4):368-379
Elbow motion is essential for upper extremity function to position the hand in space. Unfortunately, the elbow joint is prone
to stiffness following a multitude of traumatic and atraumatic etiologies. Elbow stiffness can be diagnosed with a complete
history and physical exam, supplemented with appropriate imaging studies. The stiff elbow is challenging to treat, and thus,
its prevention is of paramount importance. When this approach fails, non-operative followed by operative treatment modalities
should be pursued. Upon initial presentation in those who have minimal contractures of 6-month duration or less, static and
dynamic splinting, serial casting, continuous passive motion, occupational/physical therapy, and manipulation are non-operative
treatment modalities that may be attempted. A stiff elbow that is refractory to non-operative management can be treated surgically,
either arthroscopically or open, to eliminate soft tissue or bony blocks to motion. In the future, efforts to prevent and
treat elbow stiffness may target the basic science mechanisms involved. Our purpose was to review the etiologies, classification,
evaluation, prevention, operative, and non-operative treatment of the stiff elbow. 相似文献
57.
58.
59.
Contin Educ Anaesth Crit 相似文献
60.
Sabine J Presser Guido Schumacher Ruth Neuhaus Peter Thuss-Patience Jens Stieler Peter Neuhaus 《Liver transplantation》2007,13(3):443-450
The purpose of the study was to determine the incidence, risk factors, treatment, and influence on survival of patients with de novo esophageal cancer after liver transplantation (LT). From 1988 to 2006, 1,926 patients underwent LT in our institution. A total of 9 patients (0.5%) developed a de novo esophageal cancer and 1 patient a cancer of the cardia (0.05%). A retrospective analysis was performed to reveal underlying diseases, timeframes between LT and appearance of cancer, predisposing factors, cancer therapy, complications, immunosuppressive regimens, and survival. Of our 10 patients, 7 (70%) suffered from esophageal squamous cell carcinoma (SCC) and 3 patients (30%) developed an adenocarcinoma, including the patient with cancer of the cardia. A total of 9 patients were transplanted due to alcoholic cirrhosis; 1 patient suffered from hepatocellular carcinoma in nonA-nonB hepatitis-related cirrhosis. Median time to tumor diagnosis was 51 months after transplantation. A total of 5 patients were treated conservatively with combined radiochemotherapy and 5 underwent surgical resection. Patients with radiochemotherapy showed a mean survival of 14.8 months vs. 24.8 months for the patients of the surgery group. No major postoperative complication has been observed. A total of 2 patients of the surgery group are still alive after a follow-up of 15 and 89 months. In conclusion, de novo esophageal and cancer of the cardia after LT is a rare event. In spite of immunosuppression, no increased complication rate has been observed. Patients may have a survival benefit from surgical resection. 相似文献